Thomas Bendall

WORK HISTORY

EDUCATION

SKILLS

ABOUT THOMAS BENDALL

An award-winning, commercially driven product strategy/access director, passionate about new product development for health technologies. I specialize in building product strategy from discovery & early development, with a focus on access, evidence based healthcare and maximising lifecycle value. In doing so I help make better decisions in new product development.Recognizing the complexities and interdependencies in new product development, I shape product strategy and build/communicate value by leveraging a portfolio of technical expertise - a combination of strategic marketing, HEOR and insights & analytics - and bring a holistic perspective from diverse roles in strategy, market access, marketing and sales, complemented with experience in R&D and an appreciation for design thinking.I have worked across the spectrum of different therapy areas (immunology, infectious disease, neurology, oncology & rare disease) and customers (payers, patients and HCPs), at local (UK & Nordics), regional (EU) and global (inc. US, EU, Japan and L/LMICs) levels. I have extensive experience in matrix & line leadership across diverse teams/projects, with a track record of delivery, contribution to the P&L and developing individual and enterprise capability.I thrive in team environments where relationships, diversity of individuals & skill sets combine to enable success, alongside a collective curiosity, drive and a passion for new product development.The solutions I offer tackle key challenges in developing & launching new products, including:Shaping value- Translating scientific ideas into therapeutic value propositions (TVP)- Identifying which disease areas/indications/populations to prioritise- Identifying options for lifecycle value- Building platforms & tools to communicate the value of new productsMaximising value- Understanding customer needs to support access & uptake of new products- Aligning product strategy with customer needs - Identifying evidence needs that support evidence based decision making in healthcare via HTA, across different geographies and across the product lifecycle- Identifying barriers that may impede access & uptake- Building tools to address barriers to access & uptakeValuing value- Identifying the value of new products and building associated forecasts- Aiding investment decisions through development of investment cases.I have development and professional interests in RWD & RWE; health equity; the research and economics of longevity, and new product development in maximising a healthy lifespan.